Geode Capital Management
CRGX

Geode Capital Management’s CARGO Therapeutics CRGX Stock Holding History

Geode Capital Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-876,245
Closed -$3.61M – 4493
2025
Q2 		$3.61M Buy
876,245
+16,392
+2% +$70.2K ﹤0.01% 2895
2025
Q1 		$3.5M Buy
859,853
+5,786
+0.7% +$38.7K ﹤0.01% 2834
2024
Q4 		$12.3M Buy
854,067
+15,788
+2% +$287K ﹤0.01% 2232
2024
Q3 		$15.5M Buy
838,279
+374,018
+81% +$6.69M ﹤0.01% 2127
2024
Q2 		$7.62M Buy
464,261
+10,419
+2% +$198K ﹤0.01% 2489
2024
Q1 		$10.1M Buy
453,842
+251,060
+124% +$5.97M ﹤0.01% 2323
2023
Q4 		$4.7M Buy
+202,782
New +$3.44M ﹤0.01% 2733

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's CRGX Position: Q3 2025 in Review

Geode Capital Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 876,245 shares — an estimated $3.61M sold.

Geode Capital Management first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $15.5M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Geode Capital Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 876,245 CARGO Therapeutics shares in Q3 2025, an estimated $3.61M.
  • Geode Capital Management first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Geode Capital Management's CARGO Therapeutics position peaked at $15.5M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.